FILE PHOTO: A sign at a diagnostics site for Swiss pharmaceutical giant Roche is seen, in Burgess Hill, Britain, October 7, 2020. REUTERS/Peter Nicholls
ZURICH (Reuters) - Swiss drugmaker Roche's trial of a pill against COVID-19 in Britain has been delayed as the vaccine rollout in that country made it tough to find patients for its Phase 2 study, the company's drugs division chief said on Wednesday.
Drugs chief Bill Anderson said that Roche is now lining up additional clinical trial sites in hopes of getting the programme on track for the pill, an antiviral oral treatment called AT-527 that Roche is developing with Atea Pharmaceuticals.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
